TETRAPHASE PHARMACEUTICALS I's ticker is TTPHXXXX and the CUSIP is 88165N105. A total of 68 filers reported holding TETRAPHASE PHARMACEUTICALS I in Q2 2019. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q1 2019 | $46,000 | +17.9% | 34,166 | -1.7% | 0.00% | – |
Q4 2018 | $39,000 | -59.8% | 34,768 | -0.8% | 0.00% | – |
Q3 2018 | $97,000 | -19.2% | 35,035 | +4.3% | 0.00% | – |
Q2 2018 | $120,000 | +18.8% | 33,604 | +2.2% | 0.00% | – |
Q1 2018 | $101,000 | -53.2% | 32,892 | -4.1% | 0.00% | -100.0% |
Q4 2017 | $216,000 | -6.5% | 34,298 | +1.4% | 0.00% | 0.0% |
Q3 2017 | $231,000 | +38.3% | 33,826 | +44.1% | 0.00% | 0.0% |
Q2 2017 | $167,000 | -18.9% | 23,481 | +4.9% | 0.00% | 0.0% |
Q1 2017 | $206,000 | +145.2% | 22,390 | +7.1% | 0.00% | – |
Q4 2016 | $84,000 | -99.9% | 20,904 | -0.3% | 0.00% | – |
Q3 2016 | $80,269,000 | -10.8% | 20,958 | +0.2% | 0.00% | – |
Q2 2016 | $89,982,000 | -13.5% | 20,926 | -7.0% | 0.00% | – |
Q1 2016 | $104,000,000 | -53.8% | 22,495 | 0.0% | 0.00% | -100.0% |
Q4 2015 | $225,000,000 | +133828.6% | 22,495 | -0.2% | 0.00% | 0.0% |
Q3 2015 | $168,000 | -100.0% | 22,532 | +0.1% | 0.00% | -75.0% |
Q2 2015 | $1,067,732,000 | +64.3% | 22,507 | +26.9% | 0.00% | +33.3% |
Q1 2015 | $649,774,000 | -7.7% | 17,734 | 0.0% | 0.00% | 0.0% |
Q4 2014 | $704,217,000 | +129.0% | 17,734 | +15.1% | 0.00% | +200.0% |
Q3 2014 | $307,469,000 | +47.8% | 15,412 | -0.1% | 0.00% | 0.0% |
Q2 2014 | $208,056,000 | +100.3% | 15,423 | +61.7% | 0.00% | – |
Q1 2014 | $103,869,000 | -17.5% | 9,538 | +2.5% | 0.00% | -100.0% |
Q4 2013 | $125,858,000 | +43.2% | 9,309 | +20.6% | 0.00% | – |
Q3 2013 | $87,865,000 | – | 7,721 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
ARMISTICE CAPITAL, LLC | 664,000 | $2,543,000 | 0.82% |
GREAT POINT PARTNERS LLC | 452,375 | $1,733,000 | 0.44% |
Clearline Capital LP | 267,915 | $1,026,000 | 0.32% |
Rhenman & Partners Asset Management AB | 300,000 | $1,149,000,000 | 0.18% |
Rock Springs Capital Management LP | 662,500 | $2,537,000 | 0.16% |
Eventide Asset Management | 600,000 | $2,298,000 | 0.14% |
Granahan Investment Management | 657,496 | $2,518,000 | 0.08% |
Candriam S.C.A. | 374,000 | $1,432,000 | 0.03% |
Tekla Capital Management LLC | 192,322 | $737,000 | 0.03% |
DOW CHEMICAL CO /DE/ | 65,000 | $249,000 | 0.02% |